GSK aims to keep the Olympic Games clean
July,16, 2012
"Olympics sponsor GlaxoSmithKline (GSK) has launched its first UK advertising campaign to promote the role that anti-doping science will play in making the London Olympics the fairest possible.
The campaign launches on the same day as the official London 2012 anti-doping laboratory, which is being provided by GSK in partnership with the London Organising Committee for the Olympic and Paralympic Games (Locog) and King’s College London.
The lab, based at GSK’s Harlow, Essex, site, becomes operational 24 hours a day, seven days a week from today (16 July). More than 150 scientists, led by Professor David Cowan from the Drug Control Centre at King’s College, will carry out more tests (up to 6,250 samples) than at any other Games. Every medallist and up to 50% of all competing athletes will be tested.
The advertising campaign will feature British Olympic medal hopefuls Phillips Idowu, Beth Tweddle, David Weir, Graham Edmunds and Marlon Devonish and will appear on TV from today and outdoor advertising space across the UK from 23 July." (keep reading)
(emphasis added)
I wonder how much GSK payed for these medal hopefuls for these outdoors. Let's see if the "hopefuls" will win. Clean from the doping test but dirty because of the greed.
Money is the measure of all things.
President Barack Obama received money from the Big Pharma for his campaign. There he is!
* GSK to pay ‘unprecedented’ $3 billion fraud charge
Published on 03/07/12 at 10:09am
GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history.
The charges relate to the off-label promotion of its antidepressants Paxil and Wellbutrin for unapproved uses, such as for the treatment of children and adolescents and for sexual dysfunction."
GSK ruling: Another failing, but will the industry learn?
Published on 04/07/12 at 01:16pm
"Big pharma heads were involved in the off-label promotion of Advair/Seretide
Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles with its reputation."
GSK’s Stiefel accused of shares fraud
Published on 13/12/11 at 11:05am
The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at less than they were worth
Update:
"Anti-drug testing has traditionally been carried out by the International Olympic Committee in conjunction with the World Anti-Doping Agency and the respective national authority of each country that hosts the Games." The Guardian,
